SCHEMBL4099751

SCHEMBL4099751

COc1ccc(C(=O)c2ccc(OCCc3ccccc3)nc2)c(OC(C)(C)C(=O)OC(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
PPARG P37231 3/20 0.41
POLB P06746 2/20 0.41
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2A1 P68400 1/20 0.39
NPC1 O15118 2/20 0.39
KDM4E B2RXH2 1/20 0.38
SLC2A1 P11166 1/20 0.37
VNN1 O95497 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ELANE P08246 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
RAB9A P51151 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4111929 0.91 POLB (0.42) PPARGPOLBNPC1KDM4EVNN1
SCHEMBL4103465 0.91 PPARG (0.50) CYP11B1CYP11B2PPARGPOLBMTNR1A
SCHEMBL4096408 0.87 NPC1 (0.42) PPARGPOLBNPC1KDM4EMEN1
SCHEMBL4093282 0.85 PPARG (0.40) CYP11B1CYP11B2PPARGPOLBMTNR1A
Trifluoroacetic Acid SCHEMBL4093275 0.84 PPARG (0.47) CYP11B1CYP11B2PPARGPPARDPPARA
SCHEMBL4107809 0.82 PPARG (0.50) PPARGPOLBNPC1KDM4EELANE
SCHEMBL4099606 0.81 PPARG (0.35) CYP11B1CYP11B2PPARGPOLBNPC1
Trifluoroacetic Acid SCHEMBL4099601 0.81 PPARG (0.44) PPARGPOLBPPARDPPARA
SCHEMBL4103438 0.80 POLB (0.40) PPARGPOLBNPC1KDM4EVNN1
SCHEMBL4111694 0.80 MAPT (0.48) PPARGPOLBPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054435-A1 Phenoxyalkanoic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-26 US disclosed
EP-1911738-A1 PHENOXYALKANOIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054435-A1 Phenoxyalkanoic Acid Compound PNLIP, GPR119, LIPC CYP11B1 646/4885CYP11B2 1006/4885PPARG 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.